Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway
Li, Y.; Gong, Q.; Guo, W.; Kan, X.; Xu, D.; Ma, H.; Fu, S.; Liu, J. Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway. Int. J. Mol. Sci. 2018, 19, 1770. https://doi.org/10.3390/ijms19061770
Li Y, Gong Q, Guo W, Kan X, Xu D, Ma H, Fu S, Liu J. Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway. International Journal of Molecular Sciences. 2018; 19(6):1770. https://doi.org/10.3390/ijms19061770
Chicago/Turabian StyleLi, Yanwei, Qian Gong, Wenjin Guo, Xingchi Kan, Dianwen Xu, He Ma, Shoupeng Fu, and Juxiong Liu. 2018. "Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway" International Journal of Molecular Sciences 19, no. 6: 1770. https://doi.org/10.3390/ijms19061770